MAPT and Alzheimer disease: Dysregulation of ncRNAs has been implicated in the pathogenesis of AD, contributing to amyloid-β (Aβ) deposition, tau hyperphosphorylation, neuroinflammation, and synaptic dysfunction [14,84,85].